Neximmune Other Assets vs Other Liab Analysis
NEXI Stock | USD 3.13 0.03 0.95% |
Neximmune financial indicator trend analysis is infinitely more than just investigating Neximmune recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neximmune is a good investment. Please check the relationship between Neximmune Other Assets and its Other Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neximmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Neximmune Stock please use our How to Invest in Neximmune guide.
Other Assets vs Other Liab
Other Assets vs Other Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neximmune Other Assets account and Other Liab. At this time, the significance of the direction appears to have pay attention.
The correlation between Neximmune's Other Assets and Other Liab is -0.71. Overlapping area represents the amount of variation of Other Assets that can explain the historical movement of Other Liab in the same time period over historical financial statements of Neximmune, assuming nothing else is changed. The correlation between historical values of Neximmune's Other Assets and Other Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Assets of Neximmune are associated (or correlated) with its Other Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Liab has no effect on the direction of Other Assets i.e., Neximmune's Other Assets and Other Liab go up and down completely randomly.
Correlation Coefficient | -0.71 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Other Assets
Other Liab
Most indicators from Neximmune's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neximmune current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neximmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Neximmune Stock please use our How to Invest in Neximmune guide.As of now, Neximmune's Selling General Administrative is increasing as compared to previous years. The Neximmune's current Enterprise Value Over EBITDA is estimated to increase to 0.03, while Issuance Of Capital Stock is projected to decrease to 0.00.
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 861.4K | 576.7K | 1.0M | 702.8K | Interest Income | 52.5K | 664.4K | 973.3K | 1.0M |
Neximmune fundamental ratios Correlations
Click cells to compare fundamentals
Neximmune Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Neximmune fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 13.7M | 11.3M | 91.0M | 43.1M | 8.6M | 8.2M | |
Other Current Liab | 1.9M | 2.5M | 6.2M | 7.4M | 3.7B | 3.9B | |
Total Current Liabilities | 3.0M | 27.0M | 7.2M | 10.3M | 5.1M | 4.8M | |
Total Stockholder Equity | 10.6M | (15.8M) | 83.8M | 32.3M | 3.5M | 3.3M | |
Net Tangible Assets | (43.0M) | (69.4M) | 83.8M | 32.3M | 37.1M | 39.0M | |
Property Plant And Equipment Net | 2.6M | 2.9M | 4.4M | 5.4M | 1.4M | 1.3M | |
Net Debt | 44.5M | 14.1M | (30.3M) | (33.6M) | (3.1M) | (3.0M) | |
Retained Earnings | (47.7M) | (77.6M) | (127.7M) | (190.2M) | (222.6M) | (211.5M) | |
Accounts Payable | 1.2M | 2.8M | 1.0M | 2.4M | 1.3M | 1.8M | |
Cash | 9.1M | 5.0M | 30.3M | 34.6M | 3.2M | 3.0M | |
Non Current Assets Total | 2.7M | 2.9M | 4.8M | 5.7M | 3.2M | 3.9M | |
Non Currrent Assets Other | 103.6K | 23.4K | 324.1K | 265.0K | 1.8M | 1.9M | |
Cash And Short Term Investments | 10.1M | 5.0M | 81.8M | 34.6M | 4.6M | 4.4M | |
Common Stock Shares Outstanding | 900.9K | 910.3K | 913.2K | 962.4K | 1.0M | 1.9M | |
Liabilities And Stockholders Equity | 13.7M | 11.3M | 91.0M | 43.1M | 8.6M | 8.2M | |
Other Current Assets | 833.2K | 78.5K | 99.2K | 2.7M | 215.2K | 204.5K | |
Other Stockholder Equity | 4.7M | 8.2M | (90.8B) | 222.5M | 226.1M | 237.4M | |
Total Liab | 3.1M | 27.1M | 7.3M | 10.8M | 5.1M | 4.8M | |
Net Invested Capital | (43.0M) | (50.3M) | 83.8M | 32.3M | 3.5M | 3.7M | |
Property Plant And Equipment Gross | 2.6M | 2.9M | 6.7M | 5.4M | 3.0M | 4.1M | |
Total Current Assets | 11.0M | 8.4M | 86.3M | 37.4M | 5.4M | 5.1M | |
Net Working Capital | 8.0M | (18.6M) | 79.1M | 27.0M | 316.7K | 300.9K | |
Property Plant Equipment | 2.6M | 2.9M | 4.4M | 5.4M | 6.2M | 3.7M |
Currently Active Assets on Macroaxis
MSFT | Microsoft | |
GM | General Motors | |
CRM | Salesforce | |
MSFT | Microsoft | |
GOOG | Alphabet Inc Class C |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neximmune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Neximmune Stock please use our How to Invest in Neximmune guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Neximmune Stock analysis
When running Neximmune's price analysis, check to measure Neximmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neximmune is operating at the current time. Most of Neximmune's value examination focuses on studying past and present price action to predict the probability of Neximmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neximmune's price. Additionally, you may evaluate how the addition of Neximmune to your portfolios can decrease your overall portfolio volatility.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Neximmune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neximmune. If investors know Neximmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neximmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (30.82) | Return On Assets (0.71) | Return On Equity (1.81) |
The market value of Neximmune is measured differently than its book value, which is the value of Neximmune that is recorded on the company's balance sheet. Investors also form their own opinion of Neximmune's value that differs from its market value or its book value, called intrinsic value, which is Neximmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neximmune's market value can be influenced by many factors that don't directly affect Neximmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neximmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neximmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neximmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.